Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cabilia Pichardo, MD
Executive Director of Clinical Development
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Cancer Associates-Encintas
Encinitas, California, United States
Alberto Besseduo, MDRecruiting - Providence/st. Joe Cancer Institute/crosson Cancer Institute
Fullerton, California, United States
Yung Lyou, MDRecruiting - Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
Jennifer CarlisleRecruiting - Dana Farber Cancer Institue
Boston, Massachusetts, United States
Jacob Sands, MDRecruiting - Karmanos Cancer Institute
Detroit, Michigan, United States
Hirva Mamdani, MDRecruiting - Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Liawaty HoRecruiting - Gabrail Cancer Center Research
Canton, Ohio, United States
Nashat Gabrail, MDRecruiting - Ou Health
Oklahoma City, Oklahoma, United States
Abdul Rafeh NaqashRecruiting - Sarah Cannon Research Center
Nashville, Tennessee, United States
Recruiting - North Houston Cancer Clinics
Huntsville, Texas, United States
Elham Abbasi, MDRecruiting - Virginia Cancer Specialists
Fairfax, Virginia, United States
Alexander Spira, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2022
- Primary completion
- 31 Mar 2025
- Completion
- 31 May 2025
- Last update posted
- 16 Jul 2024
- Registered enrollment
- 36
- Registry id
- NCT05271292
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.